Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Revenue (2017 - 2025)

Selectis Health's Revenue history spans 14 years, with the latest figure at $9.7 million for Q4 2025.

  • Quarterly results put Revenue at $9.7 million for Q4 2025, down 6.98% from a year ago — trailing twelve months through Dec 2025 was $41.4 million (up 4.94% YoY), and the annual figure for FY2025 was $41.4 million, up 4.94%.
  • Revenue for Q4 2025 was $9.7 million at Selectis Health, down from $10.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $11.5 million in Q2 2022 to a low of $5.8 million in Q1 2021.
  • The 5-year median for Revenue is $9.6 million (2023), against an average of $9.4 million.
  • The sharpest move saw Revenue soared 90.71% in 2022, then decreased 22.13% in 2023.
  • Year by year, Revenue stood at $10.2 million in 2021, then increased by 5.95% to $10.8 million in 2022, then dropped by 14.78% to $9.2 million in 2023, then rose by 12.99% to $10.4 million in 2024, then decreased by 6.98% to $9.7 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $9.7 million, $10.8 million, and $10.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.